Media Doctor Australia
  

Media

 

+

 

Doctor

 

Australia

"Lung cancer treatment 'shrinks tumours'"

NineMSN

Source: NineMSN

Published: 06 Jun 2010

Category: Pharmaceutical

Rating: (3 stars)

Keywords: drug, crizotinib, tumour, lung, cancer

what they said (Hover the mouse cursor over underlined words for more info)

An experimental therapy has shown a high response rate and helps shrink tumours in lung cancer patients with a specific form of genetic alteration, according to results of a clinical trial.

The original article can be found at: http://news.ninemsn.com.au/health/1064628/lung-cancer-treatment-shrinks-tumours

how did it rate? (more information)

Criteria Rating
Total Score 5 of 9
Novelty of Treatment Satisfactory (?)
Availability of Treatment Satisfactory (?)
Treatment Options Satisfactory (?)
Disease Mongering Satisfactory (?)
Evidence Not Satisfactory (?)
Quantification of Benefits of Treatment Satisfactory (?)
Harms of Treatment Not Satisfactory (?)
Costs of Treatment Not Satisfactory (?)
Sources of Information Not Satisfactory (?)
Relies on Press Release Not Applicable

what we said (Hover the mouse cursor over underlined words for more info)

This report describes a new treatment targeted at a genetic sub-type of lung cancer. It is early days in the study of the drug and the researchers may be over-enthusiastic in describing the results as 'quite dramatic'. Comment from an independent expert could have put the results from this small study in realistic context.

public forum

There are currently no comments on this article.

voice your opinion in the forum

  • All comments and feedback submitted to Media Doctor are subject to editorial approval before being made viewable by the public. It may take up to a week for your comments to be approved. Additionally, no response will be given to questions posed in public comments. Media Doctor does not provide medical advice, or answers to medical questions posed by the public.
  • If you provide your email address it will not be displayed to the general public.
  • Comments may be edited by Media Doctor to remove defamatory or sensitive statements, and brand names.
  • Required fields are marked with an asterisk (*).
Name: *
Organisation:
Email:
Comments: *